Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Best Practice & Research. Clinical Gastroenterology
|
March 11, 2005
Clinical trial design in hepatocellular carcinoma
Philip J Johnson, Lucinda J Billingham
BJU International
|
November 17, 2007
Narrow-band imaging flexible cystoscopy in the detection of recurrent urothelial cancer of the bladder
Richard T Bryan, Lucinda J Billingham, D Michael A Wallace
Plos One
|
October 25, 2011
Excision repair cross-complementation group 1 (ERCC1) status and lung cancer outcomes: a meta-analysis of published studies and recommendations
Richard A Hubner, Richard D Riley, Lucinda J Billingham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2007
Rational selection of patients for antibacterial prophylaxis after chemotherapy
Michael H Cullen, Lucinda J Billingham, Claire H Gaunt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 23, 2017
Dose Transition Pathways: The Missing Link Between Complex Dose-Finding Designs and Simple Decision-Making
Christina Yap, Lucinda J Billingham, Ying Kuen Cheung, et al.
Trials
|
September 5, 2014
Meta-analysis of randomized phase II trials to inform subsequent phase III decisions
Danielle L Burke, Lucinda J Billingham, Alan J Girling, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
July 26, 2015
A Practical Application of Value of Information and Prospective Payback of Research to Prioritize Evaluative Research
Lazaros Andronis, Lucinda J Billingham, Stirling Bryan, et al.
Statistical Applications in Genetics and Molecular Biology
|
April 14, 2012
Sample size calculations for designing clinical proteomic profiling studies using mass spectrometry
Stephen O Nyangoma, Stuart I Collins, Douglas G Altman, et al.
Health Economics
|
May 30, 2007
Estimating the cost-effectiveness of an intervention in a clinical trial when partial cost information is available: a Bayesian approach
Paul C Lambert, Lucinda J Billingham, Nicola J Cooper, et al.
BJU International
|
May 12, 2019
Health-related quality of life around the time of diagnosis in patients with bladder cancer
Evan Yi-Wen Yu, Duncan Nekeman, Lucinda J Billingham, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Best Practice & Research. Clinical Gastroenterology
|
March 11, 2005
Clinical trial design in hepatocellular carcinoma
Philip J Johnson, Lucinda J Billingham
BJU International
|
November 17, 2007
Narrow-band imaging flexible cystoscopy in the detection of recurrent urothelial cancer of the bladder
Richard T Bryan, Lucinda J Billingham, D Michael A Wallace
Plos One
|
October 25, 2011
Excision repair cross-complementation group 1 (ERCC1) status and lung cancer outcomes: a meta-analysis of published studies and recommendations
Richard A Hubner, Richard D Riley, Lucinda J Billingham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2007
Rational selection of patients for antibacterial prophylaxis after chemotherapy
Michael H Cullen, Lucinda J Billingham, Claire H Gaunt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 23, 2017
Dose Transition Pathways: The Missing Link Between Complex Dose-Finding Designs and Simple Decision-Making
Christina Yap, Lucinda J Billingham, Ying Kuen Cheung, et al.
Trials
|
September 5, 2014
Meta-analysis of randomized phase II trials to inform subsequent phase III decisions
Danielle L Burke, Lucinda J Billingham, Alan J Girling, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
July 26, 2015
A Practical Application of Value of Information and Prospective Payback of Research to Prioritize Evaluative Research
Lazaros Andronis, Lucinda J Billingham, Stirling Bryan, et al.
Statistical Applications in Genetics and Molecular Biology
|
April 14, 2012
Sample size calculations for designing clinical proteomic profiling studies using mass spectrometry
Stephen O Nyangoma, Stuart I Collins, Douglas G Altman, et al.
Health Economics
|
May 30, 2007
Estimating the cost-effectiveness of an intervention in a clinical trial when partial cost information is available: a Bayesian approach
Paul C Lambert, Lucinda J Billingham, Nicola J Cooper, et al.
BJU International
|
May 12, 2019
Health-related quality of life around the time of diagnosis in patients with bladder cancer
Evan Yi-Wen Yu, Duncan Nekeman, Lucinda J Billingham, et al.
Page
of 3